Prof. John Gribben | ICML 2017 | Highlights of CLL

Anne Villeneuve

Natasha Fort

Jun 22, 2017

Highlights of CLL at ICML 2017

More about...

Anne Villeneuve Chronic lymphocytic leukemia ICML 2017 Monoclonal B-cell lymphocytosis Natasha Fort

Abexinostat granted FDA's Fast Track designation for the treatment of patients with relapsed or refractory follicular lymphoma

The FDA has granted abexinostat Fast Track designation as a fourth-line monotherapy for the treatment of patients with...

Sep 25, 2019

Abexinostat granted FDA's Fast Track designation for the treatment of patients with relapsed or refractory follicular lymphoma

The FDA has granted abexinostat Fast Track designation as a fourth-line...

Sep 25, 2019

ICML 2017 | Chemotherapy-free combinations for patients with B-cell NHL – Focus On Session

One of the “Focus On” Sessions at 14-ICML in Lugano, Switzerland, was based around chemotherapy-free combinations in patients with B-cell NHL, including those...

Jun 19, 2017

ICML 2017 | Chemotherapy-free combinations for patients with B-cell NHL – Focus On Session

One of the “Focus On” Sessions at 14-ICML in Lugano, Switzerland, was based around chemotherapy-free...

Jun 19, 2017

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month

First Name

Last Name

I agree to the Lymphoma Hub Terms & Conditions

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Prof. John Gribben | ICML 2017 | Highlights of CLL

Anne Villeneuve

Natasha Fort

Jun 22, 2017

More about...

Related articles

Sep 25, 2019

Sep 25, 2019

Jun 19, 2017

Jun 19, 2017

Newsletter